Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk A/S Common Stock (NYSE:NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).
诺和诺德普通股（NYSE：NVO）在星期四经历了显着下跌。此举是跟随竞争对手Viking Therapeutics Inc.（NASDAQ：VKTX）的重要公告而动作的。
What To Know: Viking Therapeutics announced the company has advanced its obesity candidate VK2735 into late-stage trials. This advancement has intensified competition in the GLP-1 market, which is currently led by Novo Nordisk and Eli Lilly corp. (NYSE:LLY).
需要注意的是：Viking Therapeutics宣布公司已将其肥胖症候选药物VK2735推进了后期试验阶段。这一进展加剧了GLP-1市场的竞争，该市场目前由Novo Nordisk和Eli Lilly corp.（NYSE：LLY）主导。
Viking Therapeutics' report of promising results for its obesity drug, showing up to a 15% reduction in body weight over 13 weeks, has pressured Novo Nordisk. This development challenges Novo Nordisk's leading position in the obesity treatment market.
Viking Therapeutics报告其肥胖症药物有希望的结果，显示在13个星期内体重减轻高达15％，这给诺和诺德带来了压力。这一进展挑战了诺和诺德在肥胖症治疗市场中的领先地位。
What Else: The options market for Novo Nordisk has shown a predominantly bearish sentiment recently. Out of eight detected trades, 62% were bearish, including three put options totaling $155,555 and five call options amounting to $255,360.
其他方面：诺和诺德的期权市场最近显示出明显的看淡情绪。在检测到的8笔交易中，有62％是看淡的，包括总计155,555美元的三只看跌期权和总计255,360美元的五只看涨期权。
Novo Nordisk's trading volume reached 1,568,565, with the stock nearing oversold conditions according to RSI indicators. The company's next earnings report is expected in 13 days.
诺和诺德的交易量达到了1,568,565，根据RSI指标，该股票接近超卖条件。公司的下一个收益报告预计在13天内发布。
Analyst Opinions: Cantor Fitzgerald recently downgraded Novo Nordisk to 'Overweight' but maintained a price target of $160.
分析师意见：Cantor Fitzgerald最近将诺和诺德股票评级下调至“超重”，但维持160美元的目标价。
NVO Price Action: Novo Nordisk shares were down by 2.88% at $127.86 according to Benzinga Pro.
根据Benzinga Pro的数据，诺和诺德的股价下跌了2.88％，报127.86美元。
- Can Independent Bank Corp. Run Higher on Rising Earnings Estimates?
- 独立银行公司（Independent Bank Corp.）是否能在收益预期上升的推动下继续上涨？
Photo via Shutterstock.
图片来自shutterstock。